Genetron

$20.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.16 (-5.46%) Today
$0.00 (0.00%) As of 9:50 PM UTC after-hours

Why Robinhood?

You can buy or sell Genetron and other stocks, options, and ETFs commission-free!

About GTH

Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China. The listed name for GTH is Genetron Holdings Limited ADS.

CEO
Si Zhen Wang
Employees
—
Headquarters
Beijing, Beijing
Founded
2015
Market Cap
1.73B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
637.81K
High Today
$21.42
Low Today
$19.98
Open Price
$21.25
Volume
385.80K
52 Week High
$21.75
52 Week Low
$9.03

Collections

GTH Earnings

-$0.19
-$0.13
-$0.06
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 8, Pre-Market

You May Also Like

OTIS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure